respiratori
virus
ubiquit
pathogen
caus
acut
respiratori
ill
age
group
viral
pneumonia
occur
frequent
extrem
agedin
young
children
elderli
adult
respiratori
virus
first
encount
children
immun
particularli
infanc
airway
small
immatur
pneumonia
may
result
although
infect
older
adult
repres
reinfect
virus
becom
frequent
caus
pneumonia
immunosenesc
presenc
chronic
medic
condit
influenza
viru
viral
pathogen
well
recogn
older
adult
caus
signific
morbid
mortal
age
group
addit
sever
common
respiratori
virus
implic
etiolog
pneumonia
older
adult
tabl
fastidi
natur
sever
virus
imperfect
diagnost
tool
burden
diseas
like
underestim
newer
investig
use
revers
transcript
polymeras
chain
reaction
rtpcr
sensit
serolog
techniqu
defin
frequenc
agent
adult
accur
sever
system
virus
see
tabl
also
caus
pneumonia
uncommon
immunocompet
older
adult
preexist
immun
although
viral
pneumonia
distinguish
reliabl
clinic
ground
alon
featur
help
clinician
judg
likelihood
viral
infect
need
laboratori
test
tabl
focu
review
role
common
respiratori
virus
immunocompet
older
adult
communityacquir
pneumonia
brief
mention
virus
caus
pneumonia
less
frequent
epidemiolog
clinic
featur
method
diagnosi
treatment
discuss
viral
contribut
communityacquir
pneumonia
adult
difficult
defin
precis
diagnost
tool
gener
insensit
publish
seri
adult
specif
elderli
rate
viral
pneumonia
vari
tremend
depend
type
test
use
popul
season
studi
virus
identifi
patient
communityacquir
pneumonia
studi
use
viral
cultur
serolog
diagnosi
tabl
recent
studi
use
rtpcr
diagnosi
improv
abil
detect
virus
consider
studi
patient
communityacquir
pneumonia
age
respiratori
virus
detect
patient
use
convent
techniqu
compar
rtpcr
studi
etiolog
communityacquir
pneumonia
regardless
diagnost
techniqu
use
influenza
viral
pathogen
identifi
commonli
account
case
influenza
virus
segment
rna
virus
classifi
b
c
base
stabl
intern
protein
influenza
virus
b
signific
human
pathogen
capabl
caus
seriou
lower
respiratori
tract
diseas
wherea
influenza
c
gener
caus
mild
upper
respiratori
tract
diseas
influenza
virus
classifi
base
two
surfac
envelop
protein
hemagglutinin
h
neuraminidas
n
glycoprotein
primari
target
neutral
antibodi
least
antigen
distinct
hemagglutinin
nine
neuraminidas
protein
describ
virus
current
primari
pathogen
human
wherea
other
gener
found
mammal
aquat
bird
rna
virus
influenza
virus
prone
high
degre
genom
mutat
replic
lead
minor
chang
h
n
protein
chang
refer
antigen
drift
account
season
influenza
epidem
influenza
segment
genom
two
influenza
virus
exchang
h
n
gene
result
virus
contain
complet
new
h
n
gene
phenomenon
refer
antigen
shift
may
result
worldwid
pandem
past
centuri
three
pandem
occur
current
two
type
virus
circul
influenza
b
virus
tend
sever
elderli
partial
immun
viru
result
exposur
earli
part
twentieth
centuri
postul
mechan
milder
diseas
age
group
influenza
previous
seen
bird
cross
speci
barrier
human
infect
occur
southeast
asia
highli
pathogen
avian
influenza
spread
bird
popul
throughout
asia
europ
date
human
infect
rare
transmiss
occur
primarili
direct
contact
infect
bird
transmiss
human
limit
possibl
mutat
allow
effici
persontoperson
spread
make
avian
influenza
greatest
pandem
threat
sinc
season
influenza
viru
predict
caus
wintertim
respiratori
diseas
epidem
usual
last
week
occur
anytim
novemb
april
highli
variabl
sever
viru
transmit
effici
small
particl
aerosol
gener
cough
sneez
thu
explos
outbreak
occur
close
set
nurs
home
influenza
result
approxim
death
hospit
admiss
unit
state
everi
year
agespecif
hospit
rate
result
influenza
form
jshape
curv
rate
high
age
declin
age
rise
significantli
age
older
rate
hospit
rise
significantli
decad
age
rise
per
age
per
age
increas
mortal
dramat
rise
per
previous
note
age
group
classic
descript
influenza
pneumonia
louria
colleagu
pandem
lower
tract
diseas
classifi
four
categori
radiograph
pneumonia
viral
infect
follow
bacteri
pneumonia
rapidli
progress
viral
pneumonia
concomit
viralbacteri
pneumonia
diffus
infiltr
previous
seen
patient
rheumat
heart
diseaseassoci
mitral
stenosi
fig
although
age
signific
risk
factor
develop
lower
respiratori
tract
complic
influenza
pure
viral
pneumonia
uncommon
outsid
pandem
set
nonimmunocompromis
host
elderli
person
partial
immun
result
previou
vaccin
natur
infect
recent
studi
highli
vaccin
elderli
commun
subsequ
document
influenza
approxim
develop
pneumonia
survey
patient
hospit
influenza
approxim
half
radiograph
find
consist
acut
diseas
definit
infiltr
atelectasi
versu
pneumonia
edema
edema
versu
infiltr
infiltr
subtl
unilater
involv
left
lower
lobe
fig
document
bacteri
infect
observ
case
pneumonia
progress
acut
respiratori
distress
syndrom
ard
death
common
influenza
limit
microbiolog
data
indic
syndrom
primari
viral
pneumonia
unlik
epidem
influenza
avian
influenza
date
sever
children
age
typic
manifest
influenza
abrupt
fever
cough
myalgia
headach
may
alter
somewhat
older
person
fever
although
still
common
may
lower
presenc
underli
cardiac
pulmonari
condit
may
obscur
diagnosi
addit
patient
cognit
impair
may
unabl
articul
symptom
among
elderli
outpati
cough
fever
acut
onset
symptom
posit
predict
valu
influenza
contrast
young
adult
triad
symptom
valu
presenc
gastrointestin
complaint
fever
myalgia
lack
signific
rhinorrhea
wheez
may
help
distinguish
influenza
respiratori
syncyti
viru
rsv
anoth
common
winter
viru
infect
control
issu
potenti
therapeut
intervent
clinician
high
index
suspicion
influenza
winter
month
particularli
viral
activ
high
diagnosi
influenza
frequent
made
basi
clinic
present
viral
activ
high
commun
cocircul
sever
respiratori
virus
howev
laboratori
confirm
gener
recommend
viral
diagnost
includ
cultur
antigen
detect
rtpcr
serolog
nasal
swab
believ
better
specimen
throat
swab
detect
influenza
virus
sputum
endotrach
secret
bronchoalveolar
lavag
specimen
also
use
detect
viru
viral
cultur
timehonor
techniqu
identifi
influenza
infect
influenza
viru
hardi
grow
well
cultur
gener
day
requir
cytopath
effect
evid
thu
cultur
limit
valu
make
therapeut
isol
decis
use
shell
viral
cultur
shorten
time
detect
approxim
hour
rapid
antigen
test
avail
influenza
b
offer
immedi
result
test
offer
sensit
approxim
sensit
greater
adult
falseneg
result
common
patient
pneumonia
neg
test
high
index
suspicion
influenza
base
clinic
ground
exist
consid
empir
treatment
molecular
test
rtpcr
offer
best
combin
sensit
specif
diagnosi
acut
influenza
labor
intens
expens
current
wide
avail
assay
use
primer
complementari
conserv
matrix
gene
rtpcr
use
patient
immunocompromis
adult
antibodi
singl
serolog
test
use
acut
diagnosi
influenza
serolog
test
demonstr
fourfold
greater
rise
influenzaspecif
antibodi
use
make
diagnosi
long
vaccin
effect
complic
interpret
four
antiviralsdamantadin
rimantadin
zanamivir
oseltamavird
approv
treatment
influenza
infect
amantadin
rimantadin
activ
influenza
wherea
zanamivir
oseltamavir
activ
influenza
b
agent
effect
prophylaxi
reduc
ill
sever
durat
symptom
viral
shed
given
within
hour
symptom
onset
uncompl
influenza
data
limit
regard
effect
antivir
treatment
influenza
pneumonia
durat
patient
symptom
admiss
usual
present
dilemma
averag
number
day
ill
day
fall
outsid
recommend
window
symptom
durat
drug
treatment
although
offici
recommend
made
risk
benefit
must
weigh
individu
clinic
situat
mani
author
believ
treatment
patient
antigen
posit
reason
signific
viral
load
secret
need
gener
posit
rapid
test
decis
made
use
antivir
therapi
import
consid
type
influenza
treat
b
issu
drug
resist
possibl
advers
reaction
specif
medic
center
diseas
control
prevent
recent
report
influenza
influenza
resist
adamantan
although
total
isol
test
isol
obtain
state
reason
use
class
drug
recommend
present
time
zanamivir
oseltamivir
effect
influenza
b
current
rate
resist
low
antivir
agent
differ
sideeffect
profil
must
consid
treatment
select
tabl
zanamivir
associ
bronchospasm
declin
forc
expiratori
volum
second
patient
underli
lung
diseas
recommend
patient
asthma
chronic
obstruct
pulmonari
diseas
copd
oseltamivir
gener
well
toler
although
approxim
recipi
experi
associ
nausea
vomit
precis
rate
bacteri
complic
nonpandem
influenza
difficult
ascertain
observ
studi
report
rang
physician
treat
frail
elderli
patient
pneumonia
document
influenza
face
challeng
decid
antibiot
need
decis
must
individu
base
durat
symptom
patient
stabil
white
blood
cell
count
result
blood
sputum
cultur
rsv
common
wintertim
respiratori
viru
affect
person
age
major
caus
seriou
lower
respiratori
tract
infect
young
children
mani
year
discoveri
rsv
consid
strictli
pediatr
pathogen
howev
recent
recogn
increasingli
seriou
adult
pathogen
human
rsv
envelop
rna
viru
member
famili
paramyxovirida
classifi
within
genu
pneumoviru
rsv
classifi
two
major
group
b
base
primarili
antigen
differ
found
one
surfac
glycoprotein
unlik
influenza
major
antigen
shift
occur
rsv
predict
caus
yearli
epidem
winter
respiratori
ill
temper
climat
activ
typic
begin
late
fall
gener
last
month
end
late
spring
unlik
influenza
tend
produc
sharp
peak
respiratori
ill
week
epidem
curv
rsv
gener
broader
estim
use
nation
health
care
databas
viral
surveil
data
indic
approxim
death
person
age
unit
state
year
attribut
rsv
sever
epidemiolog
studi
mathemat
model
indic
rsv
second
influenza
caus
seriou
viral
respiratori
diseas
adult
sever
studi
examin
frequenc
rsv
caus
communityacquir
pneumonia
estim
vari
wide
depend
diagnost
tool
use
season
studi
larg
studi
approxim
adult
admit
hospit
diagnosi
pneumonia
investig
found
rsv
identifi
case
pathogen
identifi
third
commonli
streptococcu
pneumonia
influenza
recent
studi
communityacquir
pneumonia
spain
use
combin
diagnost
techniqu
found
rsv
caus
adult
patient
pneumonia
composit
use
data
past
year
rsv
account
pneumonia
throughout
year
winter
month
although
clinic
manifest
difficult
distinguish
influenza
help
clinic
clue
suggest
rsv
infect
recent
studi
rsvand
influenza
ainfect
hospit
patient
sever
sign
symptom
found
significantli
differ
rsvinfect
subject
like
nasal
congest
wheez
product
cough
compar
influenzainfect
patient
less
like
highgrad
fever
addit
durat
symptom
admiss
day
longer
patient
rsv
compar
influenza
thu
elderli
patient
present
hospit
pneumonia
lowgrad
fever
wheez
particularli
preced
cold
diagnosi
rsv
infect
entertain
radiograph
find
associ
rsv
vari
patchi
subsegment
alveolar
densiti
lobar
consolid
recent
review
chest
radiograph
elderli
adult
hospit
rsv
known
concomit
bacteri
infect
exclud
opac
consist
pneumonia
describ
chest
radiograph
addit
infiltr
believ
atelectasi
pneumonia
opac
gener
basilar
unilater
rel
subtl
fig
patient
diffus
interstiti
infiltr
consid
typic
viral
pneumonia
bacteri
pathogen
demonstr
adult
rsv
case
although
adequaci
specimen
commonli
address
walsh
colleagu
recent
studi
hospit
patient
rsv
potenti
pathogen
identifi
adequ
sputum
sampl
posit
blood
cultur
unlik
viru
identifi
individu
larg
pulmonari
infiltr
consolid
rsv
produc
distinct
clinic
syndrom
adult
laboratori
test
requir
specif
viral
diagnosi
first
diagnost
hurdl
rsv
consider
diagnosi
rsv
known
best
pediatr
pathogen
consid
frequent
adult
addit
labil
natur
viru
low
titer
viru
nasal
secret
elderli
make
diagnosi
acut
rsv
infect
problemat
viral
cultur
rapid
antigen
test
rtpcr
use
diagnosi
acut
infect
serolog
retrospect
diagnosi
varieti
specimen
test
mean
describ
previous
includ
nasopharyng
swab
nasal
wash
sputum
bronchiolar
lavag
ideal
fig
chest
radiograph
man
histori
emphysema
admit
hospit
histori
recent
cold
lowgrad
fever
wheez
dyspnea
rsv
infect
document
viral
cultur
serolog
patchi
airspac
diseas
seen
lung
base
bilater
circumst
viral
cultur
sensit
compar
serolog
use
enzym
immunoassay
eia
unlik
influenza
commerci
rapid
antigen
test
rsv
poor
sensit
adult
studi
older
person
rsv
document
serolog
rtpcr
rapid
test
indirect
fluoresc
assay
posit
eia
rtpcr
use
success
detect
rsv
adult
popul
studi
adult
nasal
sampl
rtpcr
sensit
specif
compar
viral
cultur
sensit
specif
although
rtpcr
sensit
specif
test
current
limit
expens
labor
intens
limit
commerci
avail
nuclisen
easyq
rsv
assay
commerci
realtim
nucleic
acid
sequenc
amplif
system
use
molecular
beacon
assay
simpler
perform
tradit
rtpcr
may
repres
method
use
clinic
laboratori
adult
diagnosi
recent
data
suggest
sputum
may
better
sampl
nasal
specimen
rtpcr
use
diagnosi
infect
also
demonstr
retrospect
fourfold
greater
rise
rsvspecif
igg
either
complement
fixat
eia
rsv
adult
alway
repres
reinfect
singl
elev
titer
use
acut
diagnosi
rsvspecif
igm
detect
older
subject
acut
rsv
clinic
use
yet
defin
treatment
rsv
pneumonia
elderli
adult
larg
support
antipyret
intraven
fluid
oxygen
need
may
reason
administ
corticosteroid
bronchodil
patient
wheez
acut
although
formal
control
trial
use
agent
treatment
rsvrelat
wheez
perform
antivir
therapi
aerosol
ribavirin
rsvspecif
immunoglobulin
approv
highrisk
infant
anecdot
data
avail
adult
although
gener
use
ribavirin
recommend
use
may
consid
select
case
patient
immunocompromis
anecdot
experi
suggest
highdos
shortdur
therapi
mgml
hour
given
mask
time
day
nonintub
adult
toler
better
tent
treatment
parainfluenza
virus
piv
singlestrand
rna
virus
belong
paramyxoviru
famili
four
distinct
serotyp
recogn
term
virus
caus
croup
bronchiti
pneumonia
young
children
endem
year
round
wherea
tend
peak
fall
month
associ
often
pneumonia
children
infect
recur
throughout
adulthood
account
acut
respiratori
ill
occasion
report
pneumonia
young
adult
burden
diseas
result
piv
elderli
well
studi
pneumonia
report
investig
sweden
found
elderli
person
communityacquir
pneumonia
serolog
evid
recent
prospect
studi
nurs
home
document
piv
infect
respiratori
ill
fatal
case
bronchopneumonia
describ
piv
also
implic
precursor
outbreak
invas
pneumococc
diseas
longterm
care
facil
clinic
syndrom
character
fever
rhinorrhea
hoars
cough
sore
throat
distinct
viral
cultur
rtpcr
serolog
test
use
diagnos
piv
infect
present
time
commerci
avail
rapid
antigen
test
ribavirin
activ
vitro
piv
approv
treatment
piv
pneumonia
human
metapneumoviru
hmpv
identifi
dutch
research
young
children
bronchiol
hmpv
also
rna
viru
paramyxoviru
famili
viru
shown
worldwid
distribut
age
children
infect
temper
climat
viru
circul
predominantli
winter
month
overlap
activ
influenza
viru
rsv
sever
studi
suggest
may
signific
yeartoyear
variat
incid
rate
infect
hmpv
young
children
caus
syndrom
similar
rsv
bronchiol
pneumonia
common
manifest
asymptomat
infect
cold
asthma
exacerb
flulik
ill
document
older
children
healthi
young
adult
pneumonia
exacerb
copd
document
elderli
adult
howev
comprehens
studi
yet
publish
studi
elderli
highrisk
adult
hmpv
infect
identifi
use
rtpcr
serolog
diagnosi
twentyf
percent
patient
hospit
hmpv
infiltr
chest
radiograph
ill
may
sever
frail
elderli
evidenc
canadian
studi
pneumonia
document
hmpvinfect
nurs
home
resid
clinic
characterist
hmpv
pneumonia
older
adult
appear
distinct
wintertim
respiratori
virus
although
rate
fever
seem
higher
rsv
similar
influenza
diagnosi
hmpv
outsid
research
set
difficult
viru
special
growth
requir
cytopath
effect
take
week
detect
rtpcr
serolog
use
success
research
set
transplant
unit
assay
wide
avail
commerci
similar
piv
ribavirin
activ
vitro
approv
treatment
hmpv
infect
coronavirus
rna
virus
discov
second
frequent
caus
common
cold
rhinovirus
similar
hmpv
studi
human
ill
limit
inabl
grow
viru
routin
condit
two
group
coronavirus
identifi
four
strain
identifi
caus
acut
respiratori
ill
rang
cold
pneumonia
includ
group
group
novel
coronaviru
sarscov
repres
earli
split
group
identifi
caus
sever
acut
respiratori
syndrom
sar
epidem
origin
china
spread
quickli
distant
locat
around
world
occur
often
late
winter
earli
spring
demonstr
period
infect
healthi
adult
character
lowgrad
fever
malais
nasal
symptom
pneumonia
describ
young
children
patient
immunocompromis
elderli
use
rtpcr
coronavirus
identifi
commun
elderli
acut
respiratori
ill
recent
dutch
studi
lower
respiratori
tract
symptom
coronaviru
lower
respiratori
tract
diseas
describ
frail
elderli
attend
senior
daycar
infect
person
complain
product
cough
short
breath
studi
china
investig
examin
frequenc
clinic
featur
newli
describ
coronaviru
patient
admit
hospit
communityacquir
pneumonia
evid
coronaviru
rtpcr
case
occur
januari
may
patient
identifi
eight
age
preced
upper
respiratori
tract
symptom
note
two
patient
clinic
ill
distinguish
caus
communityacquir
pneumonia
two
patient
multipl
chronic
medic
problem
die
anoth
new
strain
coronaviru
discov
recent
found
circul
summer
autumn
associ
upper
respiratori
infect
bronchiol
asthma
exacerb
children
littl
data
h
elderli
exist
nineteen
respiratori
specimen
collect
patient
winter
respiratori
ill
canada
posit
rtpcr
pathogen
nine
elderli
person
symptom
primarili
fever
sore
throat
cough
coronaviru
studi
date
describ
radiograph
find
thu
frequenc
coronaviru
pneumonia
remain
unknown
although
sarscov
current
quiescent
clinic
syndrom
worth
describ
older
age
signific
risk
factor
death
infect
person
present
initi
fever
myalgia
cough
chill
unlik
respiratori
virus
rhinorrhea
sore
throat
uncommon
symptom
approxim
two
third
patient
develop
persist
fever
tachypnea
hypoxia
diarrhea
serial
chest
radiograph
reveal
progress
multifoc
airspac
diseas
age
coexist
medic
condit
independ
risk
factor
risk
death
patient
older
mortal
rate
exce
although
therapi
ribavirin
corticosteroid
intraven
gamma
globulin
use
treatment
sar
random
placebo
control
trial
assess
benefit
rhinovirus
frequent
caus
common
cold
circul
throughout
year
peak
fall
spring
infect
common
age
includ
elderli
account
approxim
respiratori
ill
communitydwel
elderli
outbreak
also
document
longterm
care
facil
senior
daycar
center
promin
nasal
congest
cough
constitut
symptom
character
ill
role
rhinovirus
pneumonia
remain
somewhat
controversi
replic
rhinovirus
restrict
core
bodi
temperatur
reason
rhinovirus
dismiss
caus
pneumonia
recent
rhinovirus
recov
lower
airway
experiment
challeng
case
pneumonia
describ
young
children
patient
sever
immunocompromis
role
rhinovirus
caus
communityacquir
pneumonia
older
adult
remain
determin
herp
simplex
viru
hsv
rare
caus
lower
respiratori
tract
diseas
adult
despit
fact
mucocutan
reactiv
hsv
period
stress
common
patient
risk
hsv
pneumonia
includ
immunosuppress
sever
burn
aid
trauma
age
per
se
specif
risk
factor
older
adult
may
reactiv
hsv
factor
isol
hsv
possibl
result
asymptomat
reactiv
interpret
cultur
may
difficult
exampl
hsv
isol
upper
lower
respiratori
tract
sampl
one
seri
patient
ard
howev
pathogen
unclear
herpet
pneumonia
present
either
local
dissemin
pneumonia
focal
pneumonia
attribut
direct
spread
viru
upper
tract
tracheiti
esophag
lower
tract
aspir
infect
secret
dissemin
form
result
viremia
occur
patient
sever
immunocompromis
fever
common
cough
dyspnea
chest
pain
hemoptysi
also
may
occur
mucocutan
lesion
present
patient
oral
lesion
major
patient
associ
lung
involv
contamin
bronchoalveolar
lavag
specimen
upper
airway
secret
problem
definit
diagnosi
requir
find
histolog
cytolog
examin
lower
tract
specimen
show
necrot
hemorrhag
pneumonia
viral
inclus
bodi
infect
local
mainli
trachea
larg
bronchi
thick
inflammatori
membran
mucos
ulcer
may
seen
endobronchi
biopsi
prefer
diagnosi
compar
open
lung
biopsi
acyclovir
activ
hsv
decreas
mortal
dissemin
hsv
pneumonia
children
howev
adult
ard
benefit
less
clear
control
trial
acyclovir
pneumonia
done
risk
benefit
must
weigh
individu
case
sever
virus
implic
caus
pneumonia
children
young
adult
howev
data
elderli
lack
adenovirus
particular
type
link
larg
outbreak
respiratori
diseas
sever
pneumonia
young
adult
live
congreg
set
author
experi
adenoviru
frequent
pathogen
elderli
adult
human
bocaviru
newli
discov
parvoviru
viru
identifi
rtpcr
respiratori
sampl
children
lower
respiratori
tract
ill
howev
data
avail
adult
sever
system
virus
varicella
zoster
measl
uncommonli
caus
pneumonia
acquir
adulthood
yet
uncommon
elderli
preexist
immun
hantavirus
primarili
pathogen
rodent
may
transmit
human
contact
rodent
excrement
bite
case
report
southwestern
unit
state
human
infect
result
febril
prodrom
follow
pulmonari
edema
shock
progress
may
rapid
laboratori
find
includ
elev
hematocrit
white
blood
cell
count
thrombocytopenia
treatment
support
although
primari
epsteinbarr
viru
uncommon
elderli
occur
clinic
syndrom
atyp
pneumonia
describ
age
associ
function
immunolog
declin
chronic
cardiopulmonari
diseas
predispos
pneumonia
viral
infect
occur
influenza
viru
remain
primari
viral
pathogen
elderli
although
true
impact
respiratori
virus
remain
defin
sensit
diagnost
tool
develop
unfortun
clinic
syndrom
associ
respiratori
virus
frequent
indistinguish
one
anoth
bacteri
pathogen
healthi
elderli
person
may
visit
exot
locat
place
risk
emerg
pathogen
travel
histori
import
workup
pneumonia
older
adult
antivir
therapi
avail
influenza
b
thu
specif
viral
diagnosi
may
use
clinic
manag
rapid
antigen
test
although
sensit
viral
cultur
new
molecular
techniqu
wide
avail
offer
quick
turnaround
time
rsv
piv
hmpv
coronavirus
composit
contribut
substanti
proport
communityacquir
pneumonia
case
elderli
present
time
treatment
primarili
support
